ClassID:

92536

C07C215/46 - CPC Classification

Classification description:

Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Sub-classes:
Recent Application in this class:
#1
20250206695
2025-06-26

2,5,6-TRICHLORODOPAMINE: SYNTHESIS AND APPLICATIONS

#2
20210269664
2021-09-02

2-dimensional MXene surface-modified with catechol derivative, method for preparing the same, and MXene organic ink including the same

#3
20190300498
2019-10-03

Compound, composition for forming organic film, substrate for manufacturing semiconductor apparatus, method for forming organic film, and patterning process

#4
20180079709
2018-03-22

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#5
20160368857
2016-12-22

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#6
20150238497
2015-08-27

Styrenyl derivative compounds for treating ophthalmic diseases and disorders

#7
20150166495
2015-06-18

Styrenyl derivative compounds for treating ophthalmic diseases and disorders

#8
20150166494
2015-06-18

Styrenyl derivative compounds for treating ophthalmic diseases and disorders

#9
20150119396
2015-04-30

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#10
20140121380
2014-05-01

Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol

#11
20130338208
2013-12-19

Fulvene and fulvalene analogs and their use in treating cancers

#12
20130225594
2013-08-29

Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions

#13
20120129860
2012-05-24

Styrenyl derivative compounds for treating ophthalmic diseases and disorders

#14
20090170841
2009-07-02

Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders

#15
20080275016
2008-11-06

FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS

#16
20070142381
2007-06-21

Calcium receptor modulating agents

#17
20050143426
2005-06-30

Calcium receptor modulating agents